Risk factors

Neonc Technologies Holdings (NTHI) risk factors

Item 1A of every Neonc Technologies Holdings, Inc. 10-K on file, and what changed from one year to the next.

  • FY2025 10-K risk factors

    74 risks. NeonC Technologies Holdings operates as a clinical-stage biopharmaceutical company focused on oncology product candidates NEO100 and NEO212, facing substantial recurring operating losses and going concern doubts.

    Filed Mar 31, 2026